Literature DB >> 25786088

Association of postoperative hyperglycemia with outcomes among patients with complex ventral hernia repair.

Eugene J Won1, Erik B Lehman2, Abby K Geletzke1, Matthew R Tangel1, Kazuhide Matsushima3, Deborah Brunke-Reese1, Ariana R Pichardo-Lowden4, Eric M Pauli1, David I Soybel1.   

Abstract

IMPORTANCE: Patients with medically complex conditions undergoing repair of large or recurrent hernia of the abdominal wall are at risk for early postoperative hyperglycemia, which may serve as an early warning for delays in recovery and for adverse outcomes.
OBJECTIVE: To evaluate postoperative serum glucose level as a predictor of outcome after open ventral hernia repair in patients with major medical comorbidities. DESIGN, SETTING, AND PARTICIPANTS: We performed a retrospective medical record review of 172 consecutive patients who underwent open ventral hernia repair at Penn State Milton S. Hershey Medical Center, an academic tertiary referral center, from May 1, 2011, through November 30, 2013. We initially identified patients by medical complexity and repair requiring a length of stay of longer than 1 day. MAIN OUTCOMES AND MEASURES: Postoperative recovery variables, including time to the first solid meal, length of stay, total costs of hospitalization, and surgical site occurrence.
RESULTS: Postoperative serum glucose values were available for 136 patients (79.1%), with 130 (95.6%) obtained within 48 hours of surgery. Among these patients, Ventral Hernia Working Group grade distributions included 8 patients with grade 1, 79 with grade 2, 41 with grade 3, and 8 with grade 4. Fifty-four patients (39.7%) had a postoperative glucose level of at least 140 mg/dL, and 69 patients (50.7%) required insulin administration. Both outcomes were associated with delays in the interval to the first solid meal (glucose level, ≥140 vs <140 mg/dL: mean [SD] delay, 6.4 [5.3] vs 5.6 [8.2] days; P = .01; ≥2 insulin events vs <2: 6.5 [5.5] vs 5.4 [8.4] days; P = .02); increased length of stay (glucose level, ≥140 vs <140 mg/dL: mean [SD], 8.0 [6.0] vs 6.9 [8.2] days; P = .008; ≥2 insulin events vs <2: 8.3 [6.1] vs 6.5 [8.4] days; P < .001); increased costs of hospitalization (glucose level, ≥140 vs <140 mg/dL: mean [SD], $31 307 [$20 875] vs $22 508 [$22 531]; P < .001; ≥2 insulin events vs <2: $31 943 [$22 224] vs $20 651 [$20 917]; P < .001); and possibly increased likelihood of surgical site occurrence (glucose level, ≥140 vs <140 mg/dL: 37.5% [21 of 56 patients] vs 22.5% [18 of 80 patients]; P = .06; ≥2 insulin events vs <2: 36.4% [24 of 66 patients] vs 21.4% [15 of 70 patients]; P = .06). Not all patients with diabetes mellitus developed postoperative hyperglycemia or needed more intense insulin therapy; however, 46.4% of the patients who developed postoperative hyperglycemia were not previously known to have diabetes mellitus, although most had at least 1 clinical risk factor for a prediabetic condition. CONCLUSIONS AND RELEVANCE: Postoperative hyperglycemia was associated with outcomes in patients in this study who underwent complex ventral hernia repair and may serve as a suitable target for screening, benchmarking, and intervention in patient groups with major comorbidities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25786088     DOI: 10.1001/jamasurg.2014.3160

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  4 in total

1.  S-144 lack of association between glycated hemoglobin and adverse outcomes in diabetic patients undergoing ventral hernia repair: an ACHQC study.

Authors:  Mazen R Al-Mansour; Melanie Vargas; Molly A Olson; Anand Gupta; Thomas E Read; Nelson N Algarra
Journal:  Surg Endosc       Date:  2022-08-15       Impact factor: 3.453

2.  An Elevated HbA1c Level Is Associated With Short-Term Adverse Outcomes in Patients With Gastrointestinal Cancer and Type 2 Diabetes Mellitus.

Authors:  Yingchun Huang; Huazhen Zheng; Peicong Chen; Jin Yang; Shaomin Lin; Tingting Liu; Shanwei Chen; Siqiang Lu; Junlian Chen; Wenpu Chen; Nanhai Peng
Journal:  J Clin Med Res       Date:  2017-02-21

3.  Incidence, risk factors, and outcomes of early postoperative hyperglycemia in surgical patients: a protocol for a systematic review and meta-analysis.

Authors:  Paddy Ssentongo; Joseph A Lewcun; Anna E Ssentongo; David I Soybel
Journal:  Syst Rev       Date:  2020-07-13

4.  A post-market, prospective, multi-center, single-arm clinical investigation of Phasix™ mesh for VHWG grade 3 midline incisional hernia repair: a research protocol.

Authors:  M M J van Rooijen; A P Jairam; T Tollens; L N Jørgensen; T S de Vries Reilingh; G Piessen; F Köckerling; M Miserez; A C J Windsor; F Berrevoet; R H Fortelny; B Dousset; G Woeste; H L van Westreenen; F Gossetti; J F Lange; G W M Tetteroo; A Koch; L F Kroese; J Jeekel
Journal:  BMC Surg       Date:  2018-11-20       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.